Upgrade to SI Premium - Free Trial

Anthem (ANTM) Tops Q2 EPS by 9c, Revenues In-Line; Offers FY18 EPS/Revenue Outlook

July 25, 2018 6:16 AM

Anthem (NYSE: ANTM) reported Q2 EPS of $4.25, $0.09 better than the analyst estimate of $4.16. Revenue for the quarter came in at $22.7 billion versus the consensus estimate of $22.7 billion.

"We are pleased with our second quarter 2018 financial performance, which demonstrates our ongoing commitment to delivering strong medical cost performance and innovative healthcare solutions to our members," said Gail K. Boudreaux, President and CEO. "We remain focused on improving fundamental execution across the enterprise and we expect the positive momentum exhibited in the first half of 2018 to persist for the balance of the year. We will also continue to invest in capabilities that will enable us to more effectively meet the needs of our customers and seamlessly adapt to the ever-changing healthcare landscape. I\'m excited about the growth opportunities we see ahead of us and I\'m confident that with our trusted brand and deep local market presence, we are well-positioned to gain share in our markets and deliver quality, affordable healthcare to our members."


Full Year 2018:


Anthem sees FY2018 EPS of $15.40, versus the consensus of $15.41. Anthem sees FY2018 revenue of $91-92 billion, versus the consensus of $91.33 billion.

For earnings history and earnings-related data on Anthem (ANTM) click here.


Earnings Guidance Hot Guidance Management Comments

Next Articles